Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

China announces generic drug list to reduce pharmaceutical costs

Chinese government introduces initiative to enable generic drugs to enter market and reduce prices.

The Chinese authorities are introducing an initiative which will boost the development of generic drugs. China’s National Health Commission published its first list of 34 drugs on 20 June which are off patent or nearing patent expiration and have no generic drug counterpart.

Drug manufacturers are being encouraged to make generic drugs under the drug regulator’s priority review pathway, which until now has mostly been handed to innovative drugs.

On the list include Teva’s multiple sclerosis drug Copaxone and Roche’s CMV retinitis treatment Valcyte. The Chinese government have said they will update the list at the end of each year, starting from 2020.

Small molecules and biologics on the list will be included within research and development plans supported by the Chinese government. The initiative is part of a plan to reduce drug costs in China.

Big pharma companies are in rising competition with generic drug manufacturers in China. Recently, generic drug manufacturers and suppliers won 24 out of 25 contracts to supply public hospitals in the country.

25 June 2019


0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies